NCT02350998View on ClinicalTrials.gov

Open-Label Study of OTO-201 for Middle Ear Effusion Evaluating Trans-Tympanostomy Tube Administration

PHASE3CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions
Bilateral Middle Ear Effusion
Interventions
DRUG

OTO-201

Trial Locations (5)

Unknown

Central California Ear, Nose and Throat, Fresno

Charlotte Eye, Ear, Nose and Throat Associates, Charlotte

Charlotte Eye, Ear, Nose and Throat Associates, Matthews

Piedmont Ear, Nose and Throat, Winston-Salem

Carolina Ear, Nose and Throat, Orangeburg

Sponsors

Lead Sponsor

Otonomy, Inc.
All Listed Sponsors
lead

Otonomy, Inc.

INDUSTRY